M-CSF specific monoclonal antibody and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9079956
SERIAL NO

14171330

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XOMA TECHNOLOGY LTDXOMA (US) LLC 2910 SEVENTH STREET BERKELEY CA 94710

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Calderon-Cacia, Maria Castro Valley, US 15 47
Harrowe, Gregory Martin Eugene, US 6 6
Horwitz, Arnold San Leandro, US 43 396
Kavanaugh, William M Orinda, US 7 45
Koths, Kirston El Cerrito, US 19 216
Liu, Cheng Oakland, US 258 1087
Long, Li Lafayette, US 31 431
Zimmerman, Deborah Lee Oakland, US 8 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 14, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00